Ryan Zimmerman was struggling to play through a shoulder injury and hitting just .218 with three homers and a .590 OPS in 55 games through June 23.
The next day the Nationals third baseman got a cortisone injection in his shoulder and since then he’s been on fire.
Mark Zuckerman of CSNWashington.com broke down the numbers and they’re amazing: Since the cortisone injection Zimmerman is hitting .339 with 19 homers, 21 doubles, and a 1.021 OPS in 72 games.
One of the worst hitters in baseball before the cortisone injection and one of the best hitters in baseball since the cortisone injection, which is doubly remarkable considering at the time doctors told Zimmerman that they weren’t sure how much good the shot would do on his shoulder.
Looking back on it now, here’s what Zimmerman told Zuckerman:
I’m OK with the slow starts, but not being able to swing the bat and do the things health-wise, I was worried about that. Because I know my body pretty well. Everyone in this room plays hurt. Everyone in every locker room. Nobody’s healthy. And I’ve played hurt a lot just like everyone else. But it was a different kind of feeling. It made me nervous.
That was a trying time, I guess you could say. That was about as tough a six-week stretch as I’ve ever had in my career. To be able to look up there now and know I’ve been able to battle back from that–and more importantly, can actually help the team win now–I’m pretty proud of it.
Cortisone shots for everyone!
With the Braves on the cusp of formalizing their one-year deal with Kurt Suzuki, the market for free agent catcher Matt Wieters is dwindling. ESPN’s Jerry Crasnick references an inside source that lists the Angels, Rockies and Reds as potential suitors for the 30-year-old’s services.
Wieters is coming off of an eight-year career with the Orioles. In 2016, he played through his first full year after undergoing Tommy John surgery in 2014 and batted .243/.302/.409 with 17 home runs and a .711 OPS in 464 PA. A return to Baltimore in 2017 isn’t out of the question, Crasnick writes, citing some within the team that would be open to Wieters stepping into a DH role and catching platoon with Wellington Castillo. However, he also points out that the front office appears divided on the veteran catcher, and sees the Orioles as a long shot for the foreseeable future.
The Angels have already been tied to Wieters this offseason, while the Rockies and Reds don’t appear to have made any formal inquiries so far. Both could use a veteran presence behind the dish, as the Rockies are planning to platoon rookie catcher Tom Murphy with 24-year-old Tony Wolters in the spring. The Reds, meanwhile, are banking on a quick recovery for 28-year-old Devin Mesoraco, who missed most of the 2016 season after undergoing shoulder and hip surgery and forced the club to rely almost exclusively on back-up backstop Tucker Barnhart.
The Red Sox are expecting to go to an arbitration hearing with left-handed reliever Fernando Abad, per Pete Abraham of the Boston Globe. Red Sox president Dave Dombrowski said there was a “decent chance” a hearing would be necessary after countering Abad’s $2.7 million request with $2 million.
Abad, 31, pitched just 12 2/3 innings for Boston after the club acquired him from Minnesota at the trade deadline last season. The lefty earned a cumulative 3.66 ERA, 4.2 BB/9 and 7.9 SO/9 for the two teams in 2016. He received $1.25 million in 2016 and will remain under club control (through arbitration) in 2017. A $2.7 million salary would be a hefty increase for the veteran reliever, who has seen a significant decline since he put up a 1.57 ERA for the Athletics in 2014 and who has not amassed more than 0.6 fWAR in any single season to date.
While the Red Sox aren’t close to settling with Abad, Evan Drellich of the Boston Herald reports that they may be closing in on a settlement with left-handed starter Drew Pomeranz. Pomeranz filed at $5.7 million, while the Sox felt more comfortable at $3.6 million. The two are expected to meet somewhere in the middle to avoid an arbitration hearing later this winter.